1Lin HH, Huang CC, Sheen IS. Prevalence of antibodies to hepatitis C virus in hemodialysis unit [J]. Am J Nephrol, 1991,11 : 192
2Huang CC, Wu MS, Lin DY, et al. The prevalence of hepatitis C virus antibodies in patients treated with continuous ambulatory peritonry peritoneal dialysis[J]. Pertoneal Dial Int, 1992, 12:31
3Harmit Kalia,Patricia M, Lopez,et al. Treatment of HCV in patients with renal failure[J]. Archives of Medical Research, 2007,38 : 628-633
4Mirta Remesar,Cecilia Gamba. Antibodies to hepatitis C and other viral markers in multi-transfused patients from Argentina[J]. Journal of Chnical Virology , 2005 , 34 ( Sup 2)S20-S26
5中华人民共和国卫生部.血液透析器复用操作规范[S].2005.
6[2]Sakamoto N, Enomoto N, Mayumo F. Prevalence of hepatitis C virus infection among long-term hemodialysis patients: detection of hepatitis C virus RNA in plasma. J Med Virol. 1993,39:11-15
7[4]Choo QI, Kou G, Weiner AJ, et al. Isolation of a cDNA clone derivedfrom a blood-bone non-A non-B viral hepatitis genome. Science, 1989, 244:359
8[6]Heidi P, Andreas V. Hepatitis B and C in peritoneal dialysis patients . Seminars in Nephrology, Vol 22, No 4, 2002:pp 351-360
9[7]Matthias G, Hans. Hepatitis B virus infection in hemodialysis patients. Seminars in Nephrology, Vol 22, No 4, 2002:pp340-350
10[8]Stsnislas P, Ana?s VP, Hélène F, Pascal L. HCV infection and hemodialysis. Seminars in Nephrology, Vol 22, No 4, 2002:331-339
